CHESTCOVID-19 Resource Center

COVID-19 Resource Center

Featured Content

  • Access key information at a glance with our infographics on post-intensive care syndrome, antimicrobial stewardship, asthma and COVID-19, and more. Clinical Resources
  • Read a comprehensive overview of the literature on aerosol drug delivery in the COVID-19 era. Guidelines, Statements, and Research
  • Watch recordings of recent webinars on coma science and sedation practices in patients with COVID-19, PTSD and moral distress in health care providers on the front lines, and lessons learned from past pandemics. Advice From the Front Lines

EXPLORE COVID-19 RESOURCES

icon

Clinical Resources

Find expert-vetted articles and infographics on the clinical management of COVID-19 patients, ICU administration, procedures, supply chain issues, and treatment.

icon

Advice From the Front Lines

Watch recordings of webinars featuring CHEST experts discussing COVID-19 hot topics.

icon

Guidelines, Statements, and Research

Access guidelines, statements, and key research related to the management of patients with COVID-19.

icon

Voices From the Community

Hear directly from CHEST frontline physicians on their experiences navigating the pandemic.

icon

On-Demand e-Learning

Access free e-learning modules from CHEST experts on ARDS, mechanical ventilation, hypoxemic respiratory failure, and more.

icon

CHEST Journal

Find the latest research on the COVID-19 pandemic published in the journal CHEST®.


COVID-19 burnout

Burnout and Moral Distress Among Frontline Clinicians During the COVID-19 Pandemic

The COVID-19 pandemic has presented enormous challenges to the American health care system, and prioritizing the well-being of frontline clinicians is paramount. Even before the pandemic, nearly half of US physicians reported experiencing burnout, with pulmonologists reporting a rate of 41%.

In this special issue of Clinical Perspectives, CHEST is providing a preview of research undertaken by a team of clinicians and social scientists at the University of Minnesota to explore burnout and moral distress among health care providers in ICU and acute care settings during the COVID-19 pandemic.

DOWNLOAD THE STUDY PDF »

Monoclonal Antibodies for Treating Patients With COVID-19

These investigational medications—approved for emergency use in patients by the FDA—may reduce progression to severe disease and shorten recovery in high-risk patients. Understand the types of monoclonal antibodies currently available in the US, indications for use, mechanisms of action, and NIH guidelines for this therapy.

Supported by Regeneron

ACCESS THE INFOGRAPHIC

Anti-SARS-CoV-2 Monoclonal Antibodies (mAb)

Supporter Recognition

The following companies have provided unrestricted financial support for CHEST's COVID-19 activities.

AstraZeneca
Genentech, a member of the Roche Group
GSK
Mylan
Sanofi Genzyme Regeneron

Media resources

Searching for a subject matter expert to speak with you for an article or other media on COVID-19? Need vetted, reliable data for your story? Access to the journal CHEST? We can help. Please contact media@chestnet.org to speak with our team of experts.